Scholarlink

Background <p>Argininosuccinate lyase deficiency (ASLD) is a rare autosomal recessive urea cycle disorder (UCD) resulting from mutations in the <i>ASL</i> gene. Previous studies of ASLD in patients from China have predominantly been limited to individual case reports, lacking comprehensive cohort study. This study aimed to systematically evaluate the clinical features, biochemical abnormalities, and genetic mutations of Chinese ASLD patients, thereby enhancing the understanding of the unique characteristics of this population.</p> Methods <p>We conducted a retrospective analysis of clinical and genetic data from patients diagnosed with ASLD at Shanghai Xinhua Hospital between January 2011 and May 2024.</p> Results <p>The cohort consisted of 28 Chinese ASLD patients from Xinhua Hospital. The median age of symptom onset was 18 days (range: 2 days to 6 years). Five patients (17.9%) died within the first year, and 87.0% (20/23) of survivors exhibited developmental delay. Citrulline levels were elevated in all patients. 14 out of 16 (87.5%) who underwent platelet testing demonstrated elevated platelet counts. The median blood ammonia level was 172 µmol/L (range: 9–1911 µmol/L). Early-onset cases had significantly higher ammonia levels than late-onset cases ( <i>P</i> &lt; 0.0001). Eight patients underwent liver transplantation, which normalized ammonia levels and liver function but did not prevent developmental delay. Genetic analysis identified 14 novel <i>ASL</i> variants.</p> Conclusions <p>Our study represents the largest cohort of ASLD patients from China reported to date. Despite active interventions, including liver transplantation, the prognosis remains poor, with a high prevalence of developmental delays. The identification of 14 novel pathogenic variants significantly expands the known mutation spectrum of the <i>ASL</i> gene in this population.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical, biochemical and genetic characteristics of patients with argininosuccinate lyase deficiency from a single center cohort in China

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月9日

查看全文
  • Kaichuang Zhang,
  • Deyun Lu,
  • Lili Liang,
  • Yi Yang,
  • Ruifang Wang,
  • Yuning Sun,
  • Zhuwen Gong,
  • Haijuan Zhi,
  • Wenjuan Qiu,
  • Lianshu Han

摘要

Background

Argininosuccinate lyase deficiency (ASLD) is a rare autosomal recessive urea cycle disorder (UCD) resulting from mutations in the ASL gene. Previous studies of ASLD in patients from China have predominantly been limited to individual case reports, lacking comprehensive cohort study. This study aimed to systematically evaluate the clinical features, biochemical abnormalities, and genetic mutations of Chinese ASLD patients, thereby enhancing the understanding of the unique characteristics of this population.

Methods

We conducted a retrospective analysis of clinical and genetic data from patients diagnosed with ASLD at Shanghai Xinhua Hospital between January 2011 and May 2024.

Results

The cohort consisted of 28 Chinese ASLD patients from Xinhua Hospital. The median age of symptom onset was 18 days (range: 2 days to 6 years). Five patients (17.9%) died within the first year, and 87.0% (20/23) of survivors exhibited developmental delay. Citrulline levels were elevated in all patients. 14 out of 16 (87.5%) who underwent platelet testing demonstrated elevated platelet counts. The median blood ammonia level was 172 µmol/L (range: 9–1911 µmol/L). Early-onset cases had significantly higher ammonia levels than late-onset cases ( P < 0.0001). Eight patients underwent liver transplantation, which normalized ammonia levels and liver function but did not prevent developmental delay. Genetic analysis identified 14 novel ASL variants.

Conclusions

Our study represents the largest cohort of ASLD patients from China reported to date. Despite active interventions, including liver transplantation, the prognosis remains poor, with a high prevalence of developmental delays. The identification of 14 novel pathogenic variants significantly expands the known mutation spectrum of the ASL gene in this population.